People · Operator
Named in public records as an officer, director or promoter · active 2009–2026 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SpyGlassPharma, Inc. | — | Other Health Care | Series C | $134.8M | $484.8M | 2023 |
| MetaStat, Inc. | — | Biotechnology | Series A | $39.2M | $122.2M | 2014 |
| Echo Therapeutics, Inc. | — | Other Health Care | Series A | $29.2M | $36.1M | 2009 |
| Linnaeus Therapeutics, Inc. | — | Biotechnology | Series A | $23.7M | $11.7M | 2026 |
PATRICK MOONEY at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside PATRICK MOONEY on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick T. Mooney | 3 | 3 |
| Robert Langer | 1 | 36 |
| James Smith | 1 | 20 |
| Ali Behbahani | 1 | 17 |
| Kirk Nielsen | 1 | 13 |
| Richard J. Berman | 1 | 8 |
| Geoff Pardo | 1 | 6 |
| Zach Scheiner | 1 | 6 |
| Jerome B. Zeldis | 1 | 5 |
| Bilal Khan | 1 | 5 |
| David Epstein | 1 | 5 |
| James F. Smith | 1 | 5 |
| Todd Thomson | 1 | 4 |
| Johan (Thijs) Spoor | 1 | 4 |
| Michael Poisel | 1 | 4 |
| James Demetriades | 1 | 4 |
| Walter Witoshkin | 1 | 4 |
| David Siegel | 1 | 4 |
| JOHAN (THIJS) M. SPOOR | 1 | 3 |
| Johan M Spoor | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.